The balloon catheters market attained a value of USD 4.79 Billion in 2025. The market is further expected to grow in the forecast period of 2026-2035 at a CAGR of 6.50%, to reach USD 8.99 Billion by 2035.
Base Year
Historical Period
Forecast Period
Cardiovascular disease (CVD) ranks as the leading cause of mortality globally, with recent data estimating that approximately 620 million individuals are affected by heart and circulatory diseases.
In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC. It can be used for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease.
The rising healthcare infrastructure investments and growing demand for minimally invasive procedures are key factors elevating the balloon catheter market value.
Compound Annual Growth Rate
6.5%
Value in USD Billion
2026-2035
*this image is indicative*
Balloon catheters comprise an inflatable balloon at the tip which can be often used to enlarge a narrow opening during a catheterization procedure. After the inflated balloon performs the procedure, it is deflated to remove it from the body. Balloon catheters with over-the-wire (OTW) or rapid exchange (Rx) designs are often employed during angioplasty procedures.
Balloon catheters are considered pivotal in revolutionizing minimally invasive procedures. As a result, it is experiencing high demand in the market for various medical procedures, including angioplasty and stenting. The market holds high value which can be attributed to the rising prevalence of cardiovascular diseases, growing geriatric population, and the increased adoption of technologically advanced balloon catheter technologies.
The rising technological advancement, miniaturization of devices, increased application of balloon catheters in minimally invasive procedures, and the growing geriatric population comprise some of the key trends and developments in the market.
HR Pharmaceuticals, Inc. (HRP) announced that it has signed an Exclusive Commercial Agreement with Poiesis Medical LLC, which grants HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. The dual balloon catheter technology is expected to provide better results than conventional Foley catheters. With this new addition to its urological portfolio, the company aims to improve patient outcomes and drive balloon catheters market growth.
Summa Therapeutics, LLC, The United States Food and Drug Administration (FDA) has granted approval to the Finesse Injectable angioplasty balloon catheters developed by a United States-based medical devices company, Summa Therapeutics, LLC, for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease including popliteal, iliac, femoral, and renal arteries, among others. The Finesse product line offers a port to inject radiopaque contrast material along with its role in performing balloon angioplasty, thus acting as an advanced toolset for angioplasty procedures.
Translumina Therapeutics, A leading interventional cardiovascular device company, Translumina Therapeutics, acquired Blue Medical Devices, a Netherlands-based medical technology manufacturer. Through this acquisition, the company expanded its intervention cardiology portfolio with Blue Medical’s next-generation Drug Coated Balloon Catheters, which will complement its next-generation drug eluting stents product line. The increasing incidence of such strategic collaborations is poised to boost the balloon catheters market share in coming years.
Concept Medical Inc. received an Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for its novel MagicTouch Sirolimus Coated Balloon (SCB) Catheter to treat small coronary artery disease. The approval will allow the company to test the effectiveness and safety of the device in treating the condition through appropriate clinical studies. The data generated from the trials will further help in submitting a pre-market approval (PMA) application in the United States.
The market is driven by the surge in novel product approvals by health regulatory agencies such as the United States Food and Drug Administration (FDA). The accelerated regulatory approvals for balloon catheter products foster accessibility and subsequent adoption of these advanced technologies in the healthcare sector. Moreover, it encourages health technology companies to invest significantly in the development of such products, which is expected to boost the balloon catheter market size.
The increased strategic partnerships among the key market players, rising healthcare spending, and heightened public awareness about cardiovascular health are likely to augment the market size for balloon catheters. Moreover, increased innovations in the material technology of balloon catheters such as the use of advanced polymers are also expected to drive market growth in the forecast period.
"Balloon Catheters Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Breakup by Product
Breakup by Indication
Breakup by End-user
Breakup by Region
The key market players are contributing to the balloon catheters market growth through innovative product launches, increased investments, and continuous research and development initiatives aimed at technological advancement.
| Company | Year Founded | Headquarters | Products/Services |
| Medtronic | 1949 | Dublin, Ireland | Offers a wide range of balloon catheters for cardiovascular procedures |
| Boston Scientific Corporation | 1979 | Marlborough, Massachusetts, USA | Specializes in innovative balloon catheters for coronary interventions |
| Abbott | 1888 | Abbott Park, Illinois, USA | Provides various balloon catheter products for cardiovascular treatments and interventions. |
| Spectrum Plastics Group | 1949 | Alpharetta, Georgia, USA | Manufactures advanced medical tubing extrusions and catheter components |
Other key players in the market include Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc, B. Braun SE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology (Beijing) Co., Ltd., and INVAMED.
North America holds a significant share of the market which can be attributed to the presence of an advanced healthcare system and increased demand for minimally invasive interventions. Further, the rising elderly population with a high risk of having heart and circulatory conditions, the surge in product approvals by regulatory bodies, and robust research and development initiatives are some of the factors that are expected to boost market growth in the forecast period.
In Europe, the balloon catheter market size is experiencing a steady expansion due to the rising prevalence of cardiovascular diseases in the region. It is estimated that around 45% of mortality in Europe is caused by cardiovascular diseases, which indicates the need for appropriate interventions such as advanced balloon catheter technology to tackle the rising disease burden. Moreover, the presence of leading marketing players and premium research institutes directly impacts the market dynamics in this regional market.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 4.79 Billion in 2025 driven by the rising prevalence of cardiovascular diseases across the globe.
The market is anticipated to grow at a CAGR of 6.50% during the forecast period of 2026-2035, likely to reach a market value of USD 8.99 Billion by 2035.
Advancements in balloon catheter technology and rising healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is the increased merger and acquisition initiatives among the key market players. In June 2023, Translumina Therapeutics, acquired a Blue Medical Devices (Netherlands-based medical technology manufacturer) to expand its intervention cardiology portfolio with Blue Medical’s next-generation drug coated balloon catheters.
Based on the product, the market is segmented into rapid exchange (RX) balloon catheters, over-the-wire (OTW) balloon catheters, drug eluting balloon catheters, and stent graft balloon catheters, among others.
Major end users include hospitals and ambulatory surgical centers, among others.
Based on indication, the market includes coronary artery disease and peripheral vascular disease.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Medtronic, Boston Scientific Corporation, Abbott, Spectrum Plastics Group, Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc, B. BraunSE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology (Beijing) Co., Ltd., and INVAMED.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Indication |
|
| Breakup by End-user |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share